메뉴 건너뛰기




Volumn 10, Issue 1, 2009, Pages 17-22

Metal allergic reaction in chronic refractory in-stent restenosis

Author keywords

Long term; Metal allergy; Neointimal proliferation; Stents

Indexed keywords

NICKEL; STAINLESS STEEL;

EID: 58249096172     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2008.01.004     Document Type: Article
Times cited : (43)

References (23)
  • 1
    • 0037030658 scopus 로고    scopus 로고
    • Randomized study with the sirolimus-coated BX Velocity balloon-expandable stent in the treatment of patients with de nove native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
    • On behalf of the RAVEL Study Group
    • Morice M.C., Serruys P.W., Sousa J.E., et al., On behalf of the RAVEL Study Group. Randomized study with the sirolimus-coated BX Velocity balloon-expandable stent in the treatment of patients with de nove native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
    • (2002) N Engl J Med , vol.346 , pp. 1773-1780
    • Morice, M.C.1    Serruys, P.W.2    Sousa, J.E.3
  • 2
    • 0141765805 scopus 로고    scopus 로고
    • SIRIUS sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
    • Moses J.W., Leon M.B., Popma J.J., et al. SIRIUS sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
    • (2003) N Engl J Med , vol.349 , pp. 1315-1323
    • Moses, J.W.1    Leon, M.B.2    Popma, J.J.3
  • 3
    • 0141863201 scopus 로고    scopus 로고
    • Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries; double blind, randomized controled trial (E-SIRIUS)
    • Schofer J., Schluter M., Gershlick A.H., Wijns W., Garsia E., Schampart E., Breithart G., and E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries; double blind, randomized controled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
    • (2003) Lancet , vol.362 , pp. 1093-1099
    • Schofer, J.1    Schluter, M.2    Gershlick, A.H.3    Wijns, W.4    Garsia, E.5    Schampart, E.6    Breithart, G.7    E-SIRIUS Investigators8
  • 4
    • 1542708491 scopus 로고    scopus 로고
    • The Canadian study of the sirolimus-eluting stent in the treatment of patients with ling de novo lesions in small native coronary arteries (C-SIRIUS)
    • Schampaert E., Cohen E.A., Scluter M., et al., C-CERIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with ling de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
    • (2004) J Am Coll Cardiol , vol.43 , pp. 1110-1115
    • Schampaert, E.1    Cohen, E.A.2    Scluter, M.3
  • 5
    • 9144249927 scopus 로고    scopus 로고
    • A polymer-based, paclitaxel eluting stent in patients with coronary artery disease
    • Stone G.W., Ellis S.G., Cox D.A., et al., TAXUS IV Investigators. A polymer-based, paclitaxel eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
    • (2004) N Engl J Med , vol.350 , pp. 221-231
    • Stone, G.W.1    Ellis, S.G.2    Cox, D.A.3
  • 6
    • 0037418032 scopus 로고    scopus 로고
    • Paclitaxel coating reduces in-stent intimal hyperplesia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT)
    • Hong M.K., Mintz G.S., Lee C.W., et al., Asian Paclitaxel-Eluting Stent Clinical Trial Investigatores. Paclitaxel coating reduces in-stent intimal hyperplesia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 107 (2003) 517-520
    • (2003) Circulation , vol.107 , pp. 517-520
    • Hong, M.K.1    Mintz, G.S.2    Lee, C.W.3
  • 7
    • 20044388113 scopus 로고    scopus 로고
    • Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies
    • Moreno R., Fernandez C., Hernandez R., et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
    • (2005) J Am Coll Cardiol , vol.45 , pp. 954-959
    • Moreno, R.1    Fernandez, C.2    Hernandez, R.3
  • 8
    • 0036989871 scopus 로고    scopus 로고
    • Contact allergies to metal components of the 316L steel in patients with coronary heart disease: Mat.-wiss. U
    • Hillen U., Haude M., Erbel R., and Goos M. Contact allergies to metal components of the 316L steel in patients with coronary heart disease: Mat.-wiss. U. Werkstofftech 33 (2002) 747-750
    • (2002) Werkstofftech , vol.33 , pp. 747-750
    • Hillen, U.1    Haude, M.2    Erbel, R.3    Goos, M.4
  • 12
    • 58249116560 scopus 로고    scopus 로고
    • Summary of safety and effectiveness data. Cypher™ Sirolimus-eluting OTW and RX CSS PMA#P020026.
    • Summary of safety and effectiveness data. Cypher™ Sirolimus-eluting OTW and RX CSS PMA#P020026.
  • 13
    • 58249105766 scopus 로고    scopus 로고
    • 2™ Coronary Stent System. PMA#P030025.
    • 2™ Coronary Stent System. PMA#P030025.
  • 14
    • 0032998165 scopus 로고    scopus 로고
    • Outcome of target sites escaping high-grade (>70%) restenosis after percutaneous transluminal coronary angioplasty
    • Saito T., Date H., Taniguchi I., et al. Outcome of target sites escaping high-grade (>70%) restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 83 (1999) 857-861
    • (1999) Am J Cardiol , vol.83 , pp. 857-861
    • Saito, T.1    Date, H.2    Taniguchi, I.3
  • 15
    • 0037172986 scopus 로고    scopus 로고
    • Morphological predictors of restenosis after coronary stenting in humans
    • Farb A., Weber D.K., Kolodgie F.D., Burke A.P., and Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 105 (2002) 2974-2980
    • (2002) Circulation , vol.105 , pp. 2974-2980
    • Farb, A.1    Weber, D.K.2    Kolodgie, F.D.3    Burke, A.P.4    Virmani, R.5
  • 16
    • 0141885290 scopus 로고    scopus 로고
    • Pathological mechanisms of fatal late coronary stent thrombosis in humans
    • Farb A., Burke A.P., Kolodgie F.D., and Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108 (2003) 1701-1706
    • (2003) Circulation , vol.108 , pp. 1701-1706
    • Farb, A.1    Burke, A.P.2    Kolodgie, F.D.3    Virmani, R.4
  • 17
    • 0036305358 scopus 로고    scopus 로고
    • Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent
    • Klugherz B.D., Llanos G., Lieuallen W., et al. Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent. Coron Artery Dis 13 (2002) 183-188
    • (2002) Coron Artery Dis , vol.13 , pp. 183-188
    • Klugherz, B.D.1    Llanos, G.2    Lieuallen, W.3
  • 19
    • 22144474043 scopus 로고    scopus 로고
    • Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents
    • Finn A.V., Kolodgie F.D., Harnek J., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 (2005) 270-278
    • (2005) Circulation , vol.112 , pp. 270-278
    • Finn, A.V.1    Kolodgie, F.D.2    Harnek, J.3
  • 20
    • 0001637360 scopus 로고    scopus 로고
    • Silicon carbide as an anti-thrombogenic stent coating: an example of science-based development strategy
    • Rzany A., Harder C., and Schaldach M. Silicon carbide as an anti-thrombogenic stent coating: an example of science-based development strategy. Prog Biomed Res 5 (2000) 168-178
    • (2000) Prog Biomed Res , vol.5 , pp. 168-178
    • Rzany, A.1    Harder, C.2    Schaldach, M.3
  • 21
    • 0038415148 scopus 로고    scopus 로고
    • Smart material silicon carbide: reduced activation of cells and proteisns on a-SiC: H-coated syainless steel
    • Rzany A., Harder C., and Schaldach M. Smart material silicon carbide: reduced activation of cells and proteisns on a-SiC: H-coated syainless steel. Prog Biomed Res (2001) 182-194
    • (2001) Prog Biomed Res , pp. 182-194
    • Rzany, A.1    Harder, C.2    Schaldach, M.3
  • 22
    • 0034462598 scopus 로고    scopus 로고
    • Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells
    • Sullivan K.E., Cutilli J., Piliero L.M., Ghavimi-Alagha D., et al. Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 7 6 (2000) 920-924
    • (2000) Clin Diagn Lab Immunol , vol.7 , Issue.6 , pp. 920-924
    • Sullivan, K.E.1    Cutilli, J.2    Piliero, L.M.3    Ghavimi-Alagha, D.4
  • 23
    • 33750891887 scopus 로고    scopus 로고
    • Nickel, cobalt, chromium, palladium and gold induce a mixed Th1- and Th2-cytokine response in vitro in subjects with contact allergy the respective metals
    • Minang J.T., Areström I., Troye-Blomberg M., Lunderberg L., and Ahlborg N. Nickel, cobalt, chromium, palladium and gold induce a mixed Th1- and Th2-cytokine response in vitro in subjects with contact allergy the respective metals. Clin Exp Immunol 146 (2006) 417-726
    • (2006) Clin Exp Immunol , vol.146 , pp. 417-726
    • Minang, J.T.1    Areström, I.2    Troye-Blomberg, M.3    Lunderberg, L.4    Ahlborg, N.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.